These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 32115477

  • 1. [Pharmacological profile and clinical findings of nalmefene (Selincro®) for reducing alcohol consumption in patients with alcohol dependence].
    Tadori Y.
    Nihon Yakurigaku Zasshi; 2020; 155(2):113-119. PubMed ID: 32115477
    [Abstract] [Full Text] [Related]

  • 2. [Alcohol dependence and opioid receptor -Pharmacological profile of nalmefene].
    Ohgi Y.
    Nihon Yakurigaku Zasshi; 2020; 155(3):145-148. PubMed ID: 32378631
    [Abstract] [Full Text] [Related]

  • 3. Nalmefene: a review of its use in the treatment of alcohol dependence.
    Keating GM.
    CNS Drugs; 2013 Sep; 27(9):761-72. PubMed ID: 23949908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of nalmefene in Japanese patients with alcohol dependence.
    Higuchi S, Takahashi M, Murai Y, Tsuneyoshi K, Nakamura I, Meulien D, Miyata H.
    Psychiatry Clin Neurosci; 2020 Aug; 74(8):431-438. PubMed ID: 32359104
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
    Soyka M.
    Expert Opin Pharmacother; 2016 Aug; 17(4):619-26. PubMed ID: 26810044
    [Abstract] [Full Text] [Related]

  • 10. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
    Mann K, Bladström A, Torup L, Gual A, van den Brink W.
    Biol Psychiatry; 2013 Apr 15; 73(8):706-13. PubMed ID: 23237314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.
    Alcohol Clin Exp Res; 2007 Jul 15; 31(7):1179-87. PubMed ID: 17451401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Benefits in reducing alcohol consumption: how nalmefene can help].
    Bendimerad P, Blecha L.
    Encephale; 2014 Dec 15; 40(6):495-500. PubMed ID: 25454365
    [Abstract] [Full Text] [Related]

  • 16. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
    Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ.
    Neuropsychopharmacology; 2005 Dec 15; 30(12):2254-62. PubMed ID: 15988468
    [Abstract] [Full Text] [Related]

  • 17. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG.
    Adicciones; 2015 Sep 29; 27(3):214-30. PubMed ID: 26437315
    [Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
    van den Brink W, Strang J, Gual A, Sørensen P, Jensen TJ, Mann K.
    Expert Opin Drug Saf; 2015 Apr 29; 14(4):495-504. PubMed ID: 25652768
    [Abstract] [Full Text] [Related]

  • 19. κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats.
    Nealey KA, Smith AW, Davis SM, Smith DG, Walker BM.
    Neuropharmacology; 2011 Apr 29; 61(1-2):35-42. PubMed ID: 21338616
    [Abstract] [Full Text] [Related]

  • 20. Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.
    Zhou Y, Kreek MJ.
    Brain Res; 2019 Dec 01; 1724():146410. PubMed ID: 31469985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.